Swedish Cancer Center

Seattle, Washington 98122

1 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Cancer of the Prostate, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B Cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Diffuse Large-cell B-cell Lymphoma, Endometrial Adenocarcinoma, Follicular Lymphoma (FL), High Grade Non-Hodgkin's Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin

Studies at this site

• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
• A Phase 1 Study of ADI-001 in B Cell Malignancies — Stopped early
• Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL) — Stopped early
• CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution — Completed
• A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma — Stopped early
• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early